Skip to main content

An effective and safe targeted therapy for treatment of Myasthenia gravis

Project description

Innovative tolerance technology for the treatment of autoimmune disease

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

TOLERANZIA AB
Net EU contribution
€ 50 000,00
Address
Erik Dahlbergsgatan 11 A
411 26 Goteborg
Sweden

See on map

Region
Södra Sverige Västsverige Västra Götalands län
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 21 429,00